| For: | Zheng HX, Wu LN, Xiao H, Du Q, Liang JF. Inhibitory effects of dobutamine on human gastric adenocarcinoma. World J Gastroenterol 2014; 20(45): 17092-17099 [PMID: 25493021 DOI: 10.3748/wjg.v20.i45.17092] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17092.htm |
| Number | Citing Articles |
| 1 |
Priyanka Samji, Manoj K. Rajendran, Vidya P. Warrier, Akshayaa Ganesh, Karunagaran Devarajan. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective. Cellular Signalling 2021; 78 doi: 10.1016/j.cellsig.2020.109858
|
| 2 |
Hiroshi Shimada, Shyuetsu Abe, Takayuki Kohno, Seiro Satohisa, Takumi Konno, Syunta Takahashi, Tsubasa Hatakeyama, Chihiro Arimoto, Takuya Kakuki, Yakuto Kaneko, Ken-ichi Takano, Tsuyoshi Saito, Takashi Kojima. Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer. Scientific Reports 2017; 7(1) doi: 10.1038/srep37049
|
| 3 |
Takayuki Kohno, Takashi Kojima. Atypical Macropinocytosis Contributes to Malignant Progression: A Review of Recent Evidence in Endometrioid Endometrial Cancer Cells. Cancers 2022; 14(20) doi: 10.3390/cancers14205056
|
| 4 |
Yiting Qiao, Tongyu Li, Shusen Zheng, Hangxiang Wang. The Hippo pathway as a drug target in gastric cancer. Cancer Letters 2018; 420 doi: 10.1016/j.canlet.2018.01.062
|
| 5 |
Takayuki Kohno, Takumi Konno, Takashi Kojima. Role of Tricellular Tight Junction Protein Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Cancer Cells. International Journal of Molecular Sciences 2019; 20(14) doi: 10.3390/ijms20143555
|
| 6 |
Zhenxue Tang, Qingxia Ma, Luyao Wang, Chaolong Liu, Hui Gao, Zhihong Yang, Zhantao Liu, Huimin Zhang, Lixia Ji, Guohui Jiang. A brief review: some compounds targeting YAP against malignancies. Future Oncology 2019; 15(13) doi: 10.2217/fon-2019-0035
|
| 7 |
Niamat Ali Khan, Nicolas Willemarck, Ali Talebi, Arnaud Marchand, Maria Mercedes Binda, Jonas Dehairs, Natalia Rueda-Rincon, Veerle W. Daniels, Muralidhararao Bagadi, Deepak Balaji Thimiri Govinda Raj, Frank Vanderhoydonc, Sebastian Munck, Patrick Chaltin, Johannes V. Swinnen. Identification of drugs that restore primary cilium expression in cancer cells. Oncotarget 2016; 7(9) doi: 10.18632/oncotarget.7198
|
| 8 |
Shohreh Fakhari, Azzurra Stefanucci, Adriano Mollica, Bahram Nikkhoo, Elham Tafsiri, Ali Jalili, Sako Mirzaie. Designing new generation of potent inhibitors against membrane-type matrix metalloproteinase-2: a computational effort against multiple myeloma. Journal of Biomolecular Structure and Dynamics 2020; 38(13) doi: 10.1080/07391102.2019.1670736
|
| 9 |
Violina Baranauskaite Barbosa, Pedro F. Costa-Silva, Henrique Araújo-Silva, Gonçalo Miranda, Jorge Correia-Pinto, Rute Silva Moura. Molecular insights of Hippo signaling in the chick developing lung. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2023; 1866(1) doi: 10.1016/j.bbagrm.2022.194904
|
| 10 |
Renya Zeng, Jixin Dong. The Hippo Signaling Pathway in Drug Resistance in Cancer. Cancers 2021; 13(2) doi: 10.3390/cancers13020318
|
| 11 |
Bingqian Xie, Zhijian Xu, Guang Yang, Gege Chen, Bo Li, Liangning Hu, Wenqin Xiao, Xi Sun, Minjie Gao, Lu Gao, Xiaosong Wu, Yi Tao, Weiliang Zhu, Jumei Shi. Antitumor effect of dobutamine on multiple myeloma via mitogen-activated protein kinase pathwayin vitro. Acta Biochimica et Biophysica Sinica 2016; 48(12) doi: 10.1093/abbs/gmw110
|
| 12 |
Shuai Ye, T.S. Karin Eisinger-Mathason. Targeting the Hippo pathway: Clinical implications and therapeutics. Pharmacological Research 2016; 103 doi: 10.1016/j.phrs.2015.11.025
|
| 13 |
Thomas Andl, Linli Zhou, Kun Yang, Ana Luisa Kadekaro, Yuhang Zhang. YAP and WWTR1: New targets for skin cancer treatment. Cancer Letters 2017; 396 doi: 10.1016/j.canlet.2017.03.001
|
| 14 |
Nafiseh Jirofti, Farkhonde Sarhaddi, Afsaneh Jahani, Abbas Rahdar, Fatemeh Kalalinia, Rahime Eshaghi Malekshah, Zahra Ebrahimnezhad, Niloufar Rahiman, Sonia Fathi-karkan, Pablo Taboada, Sadanand Pandey. Development and Characterization of Polymer-stabilized Dobutamine Nanomicelles for Improved Drug Delivery. Nano LIFE 2026; 16(02) doi: 10.1142/S1793984425500023
|
| 15 |
Safa Daoud, Alaa Abuawad, Rana Abu-Dahab, Mutasem. O. Taha. ROCK2 Inhibition Underlying the Anticancer Effects of Dobutamine: A Novel Proposed Mechanism. The Open Medicinal Chemistry Journal 2026; 20(1) doi: 10.2174/0118741045455658260423122147
|
| 16 |
Luca Fabris, Chiara Milani, Romina Fiorotto, Valeria Mariotti, Eleanna Kaffe, Barbara Seller, Aurelio Sonzogni, Mario Strazzabosco, Massimiliano Cadamuro. Dysregulation of the Scribble/YAP/β‐catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis. The FASEB Journal 2022; 36(6) doi: 10.1096/fj.202101924R
|
| 17 |
Luo Yuan Yuan, Wu Shuai, Zou Yuan-Peng, Jiang Ting, Xia Wei, He Yu-Qin, Hong Huang-ming. Relationship between Yes-Associated Protein 1 and Prognosis of Digestive System Neoplasm: Quantitative Analysis and Bioinformatics Analysis Based on 4023 Patients. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/3798694
|
| 18 |
Zhipeng Tao, Xu Wu. Transcription Factor Regulatory Networks. Methods in Molecular Biology 2023; 2594 doi: 10.1007/978-1-0716-2815-7_9
|
| 19 |
Lornella Seeneevassen, Pierre Dubus, Caroline Gronnier, Christine Varon. Hippo in Gastric Cancer: From Signalling to Therapy. Cancers 2022; 14(9) doi: 10.3390/cancers14092282
|
| 20 |
Jun Ma, Jenny Wang, Laleh Soltan Ghoraie, Xin Men, Benjamin Haibe-Kains, Penggao Dai. A Comparative Study of Cluster Detection Algorithms in Protein–Protein Interaction for Drug Target Discovery and Drug Repurposing. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00109
|
| 21 |
Ruizheng Feng, Junsheng Gong, Lina Wu, Lei Wang, Baolin Zhang, Gang Liang, Huixia Zheng, Hong Xiao. MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma. Oncology Reports 2017; 38(2) doi: 10.3892/or.2017.5774
|
| 22 |
Raffaella Catalano, Roberta Rocca, Giada Juli, Giosuè Costa, Annalisa Maruca, Anna Artese, Daniele Caracciolo, Pierosandro Tagliaferri, Stefano Alcaro, Pierfrancesco Tassone, Nicola Amodio. A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. European Journal of Medicinal Chemistry 2019; 183 doi: 10.1016/j.ejmech.2019.111715
|
| 23 |
Eduarda Ribeiro, Nuno Vale. Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects. Targets 2024; 2(2) doi: 10.3390/targets2020009
|
| 24 |
Xianbin Zhang, Ahmed Abdelrahman, Brigitte Vollmar, Dietmar Zechner. The Ambivalent Function of YAP in Apoptosis and Cancer. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123770
|
| 25 |
MANMAN SU, WEIQIN CHANG, DINGDING WANG, MANHUA CUI, YANG LIN, SHUYING WU, TIANMIN XU. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells. Oncology Reports 2015; 34(3) doi: 10.3892/or.2015.4118
|
| 26 |
Roberta Melchionna, Paola Trono, Anna Di Carlo, Francesca Di Modugno, Paola Nisticò. Transcription factors in fibroblast plasticity and CAF heterogeneity. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02934-4
|
| 27 |
Shunta Nagashima, Junichi Maruyama, Shodai Kawano, Hiroaki Iwasa, Kentaro Nakagawa, Mari Ishigami‐Yuasa, Hiroyuki Kagechika, Hiroshi Nishina, Yutaka Hata. Validation of chemical compound library screening for transcriptional co‐activator with PDZ‐binding motif inhibitors using GFP‐fused transcriptional co‐activator with PDZ‐binding motif. Cancer Science 2016; 107(6) doi: 10.1111/cas.12936
|
| 28 |
Shohreh Fakhari, Ali Jalili, Bahram Nikkhoo, Bayazid Ghaderi, Mohammad Amin Boshagh, Sako Mirzaie, Mohammad Moradzad. MT2-MMP is differentially expressed in multiple myeloma cells and mediates their growth and progression. Cellular Signalling 2022; 92 doi: 10.1016/j.cellsig.2022.110248
|